Lönn, SE
Hans Lönn, Lund SE
Patent application number | Description | Published |
---|---|---|
20090105239 | 2-PYRIDINE DERIVATIVES AS INHIBITORS OF NEUTROPHILE ELASTASE - The invention provides compounds of formula wherein R | 04-23-2009 |
20090131483 | 2-PYRIDINE DERIVATIVES AS INHIBITORS OF NEUTROPHILE ELASTASE - The invention provides compounds of formula (I) wherein R | 05-21-2009 |
20090131486 | 2-PYRIDONE DERIVATIVES FOR THE TREATMENT OF DISEASE OR CONDITION IN WHICH INHIBITION OF NEUTROPHIL ELASTASE ACTIVITY IS BENEFICIAL - The invention provides compounds of formula | 05-21-2009 |
20090209555 | 2-PYRAZINONE DERIVATIVES FOR THE TREATMENT OF DISEASE OR CONDITION IN WHICH INHIBITION OF NEUTROPHIL ELASTASE ACTIVITY IS BENEFICIAL - The invention provides compounds of formula | 08-20-2009 |
20100280048 | Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase - The invention provides certain novel 6-heteroaryl-5-methyl-3-oxo-4-[3(trifluoromethyl)phenyl]-3,4-dihydropyrazine-2-carboxamide derivatives and pharmaceutically acceptable salts thereof and particular Forms thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of human neutrophil elastase. | 11-04-2010 |
20110003858 | MULTIMERIC HETEROCYCLIC COMPOUNDS USEFUL AS NEUTROPHIL ELASTASE INHIBITORS - The invention provides compounds of formula (I) and formula (IV) (M)-(L)-(M) (I) [(M)-(L | 01-06-2011 |
20120108610 | 2-PYRAZINONE DERIVATIVES FOR THE TREATMENT OF DISEASE OR CONDITION IN WHICH INHIBITION OF NEUTROPHIL ELASTASE ACTIVITY IS BENEFICIAL - The invention provides compounds of formula | 05-03-2012 |
Hans Lönn, Lund SE
Patent application number | Description | Published |
---|---|---|
20090209555 | 2-PYRAZINONE DERIVATIVES FOR THE TREATMENT OF DISEASE OR CONDITION IN WHICH INHIBITION OF NEUTROPHIL ELASTASE ACTIVITY IS BENEFICIAL - The invention provides compounds of formula | 08-20-2009 |
20110003858 | MULTIMERIC HETEROCYCLIC COMPOUNDS USEFUL AS NEUTROPHIL ELASTASE INHIBITORS - The invention provides compounds of formula (I) and formula (IV) (M)-(L)-(M) (I) [(M)-(L | 01-06-2011 |
20120035157 | 2-PYRIDONE DERIVATIVES AS NEUTROPHIL ELASTASE INHIBITORS AND THEIR USE - There are provided novel compounds of formula (I), | 02-09-2012 |
Hans Roland Lönn, Lund SE
Patent application number | Description | Published |
---|---|---|
20100216843 | NOVEL SALT 628 - 6-Methyl-5-(1-methyl-1H-pyrazol-5-yl)-N-{[5-(methylsulfonyl)pyridin-2-yl]methyl}-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide 4-methylbenzenesulfonate and a novel crystalline form thereof are disclosed together with processes for preparing such salt and form, pharmaceutical compositions comprising such a salt and form, and the methods of treatment using such a salt and form. | 08-26-2010 |
20120269872 | NOVEL SALT 628 - 6-M ethyl-5-(1-methyl-1H-pyrazol-5-yl)-N-{[5-(methylsulfonyl)pyridin-2-yl]methyl}-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide 4-methylbenzenesulfonate and a novel crystalline form thereof are disclosed together with processes for preparing such salt and form, pharmaceutical compositions comprising such a salt and form, and the methods of treatment using such a salt and form. | 10-25-2012 |
Hans Roland Lönn, Lund SE
Patent application number | Description | Published |
---|---|---|
20100216843 | NOVEL SALT 628 - 6-Methyl-5-(1-methyl-1H-pyrazol-5-yl)-N-{[5-(methylsulfonyl)pyridin-2-yl]methyl}-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide 4-methylbenzenesulfonate and a novel crystalline form thereof are disclosed together with processes for preparing such salt and form, pharmaceutical compositions comprising such a salt and form, and the methods of treatment using such a salt and form. | 08-26-2010 |
Urban Lönn, Uppsala SE
Patent application number | Description | Published |
---|---|---|
20090177145 | MEDICAL DEVICE AND METHOD FOR MONITORING HEMATOCRIT AND SVO2 - A method, an implantable medical device, and a computer-readable medium encoded with programming instructions allow monitoring of a hematocrit value and an SvO2 level of a patient, making use of at least one medical lead connected to an implantable medical device that carries an optical sensor module that measures at least one hematocrit value and at least one SvO2 value using at least first, second and third light radiation wavelengths, by determining a present hematocrit value from at least one of the measured hematocrit values and determining a present SvO2 value from at least one of the measured SvO2 values, and determining a patient status by evaluating the present hematocrit value and the present SvO2 value, to allow a change in the patient status to be identified. | 07-09-2009 |
20100041970 | IMPLANTABLE MEDICAL DEVICE - An implantable medical device has an oxygen sensor adapted to measure the level of oxygen in oxygenized blood, and to generate an oxygen measurement signal in dependence of the level of oxygen. The oxygen sensor is adapted to perform measurements inside the heart, of blood entering the left atrium of a patient's heart. The obtained oxygen measurement signal is compared to a predetermined threshold level and an indication signal is generated in dependence of the comparison. The, indication signal is indicative of the lung functionality of the patient. | 02-18-2010 |
20100106210 | IMPLANTABLE MEDICAL SYSTEM FOR DETECTING INCIPIENT EDEMA - An implantable medical system for detecting incipient edema has an implantable medical lead including an optical sensor having a light source and a light detector. The medical system further has an edema detection circuit that activates the light source to emit light, the light being directed into lung tissue of a patient and that obtains a light intensity value corresponding to an intensity of light received by the light detector, and that evaluates the light intensity value to detect a consistency with incipient edema. | 04-29-2010 |
20100185252 | DEVICE AND METHOD OF A MEDICAL IMPLANT FOR MONITORING PROGRESSION OF HEART FAILURE IN A HUMAN HEART - In a device and method for a medical implant for monitoring progression of heart failure in a human heart, an activity sensor provides information related to the activity level of a patient and an oxygen sensor provides information related to the level of oxygen content in venous blood. A determined level of venous oxygen content at a determined activity level is obtained, and that level of venous oxygen content is compared to stored values at a corresponding activity level. The result of the comparison is used as a basis for determining a degree of heart failure. | 07-22-2010 |
Urban Lönn, Uppsala SE
Patent application number | Description | Published |
---|---|---|
20100041970 | IMPLANTABLE MEDICAL DEVICE - An implantable medical device has an oxygen sensor adapted to measure the level of oxygen in oxygenized blood, and to generate an oxygen measurement signal in dependence of the level of oxygen. The oxygen sensor is adapted to perform measurements inside the heart, of blood entering the left atrium of a patient's heart. The obtained oxygen measurement signal is compared to a predetermined threshold level and an indication signal is generated in dependence of the comparison. The, indication signal is indicative of the lung functionality of the patient. | 02-18-2010 |
20100106210 | IMPLANTABLE MEDICAL SYSTEM FOR DETECTING INCIPIENT EDEMA - An implantable medical system for detecting incipient edema has an implantable medical lead including an optical sensor having a light source and a light detector. The medical system further has an edema detection circuit that activates the light source to emit light, the light being directed into lung tissue of a patient and that obtains a light intensity value corresponding to an intensity of light received by the light detector, and that evaluates the light intensity value to detect a consistency with incipient edema. | 04-29-2010 |
20100185252 | DEVICE AND METHOD OF A MEDICAL IMPLANT FOR MONITORING PROGRESSION OF HEART FAILURE IN A HUMAN HEART - In a device and method for a medical implant for monitoring progression of heart failure in a human heart, an activity sensor provides information related to the activity level of a patient and an oxygen sensor provides information related to the level of oxygen content in venous blood. A determined level of venous oxygen content at a determined activity level is obtained, and that level of venous oxygen content is compared to stored values at a corresponding activity level. The result of the comparison is used as a basis for determining a degree of heart failure. | 07-22-2010 |
Viktoria Lönn, Osterskar SE
Patent application number | Description | Published |
---|---|---|
20100185214 | SANITARY DEVICE FOR REMOVAL OF BLACKHEADS AND PIMPLES - A sanitary device for removal of blackheads and pimples. According to the invention, the sanitary device comprises two elongated sticks held in respective hands of a user, each stick formed of an elongated body having a handling portion and a treatment portion, the treatment portion being rounded and having a suitable surface roughness. | 07-22-2010 |
Viktoria Lönn, Osterskar SE
Patent application number | Description | Published |
---|---|---|
20100185214 | SANITARY DEVICE FOR REMOVAL OF BLACKHEADS AND PIMPLES - A sanitary device for removal of blackheads and pimples. According to the invention, the sanitary device comprises two elongated sticks held in respective hands of a user, each stick formed of an elongated body having a handling portion and a treatment portion, the treatment portion being rounded and having a suitable surface roughness. | 07-22-2010 |